GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED

22 Dec 2025 - 24 Dec 2025 Individual Category Main Board BSE NSE

Min Investment

₹14592

Price Band

₹108-₹114

Issue Size

₹150.79 Cr

Lot Size

128 (per lot)

IPO Dates
img

22 Dec 2025

Open Date

img

24 Dec 2025

Close Date

img

26 Dec 2025

Allotment Date

img

30 Dec 2025

Listing Date

Know Before Investing

Strengths icon

  • Strong capabilities in renal sciences with established urology subspecialties.
  • Strategically located, right-sized hospitals providing efficient capital returns.
  • Proven ability to attract, train, and retain skilled medical professionals.
  • Continuous investment in infrastructure and clinical processes supporting affordable care.
  • Strong operational and financial performance with a track record of growth.

Weaknesses icon

  • The company has acquired several hospitals from promoters and may continue such related-party acquisitions.
  • Acquisitions and integrations involve operational, financial, and regulatory risks.
  • Rapid expansion across multiple hospitals increases management and operational complexity.
  • Dependence on promoter-led expertise poses concentration and continuity risks.
  • Hospitals lacking certain departments may limit service breadth.

About Gujarat Kidney And Super Speciality Limited

Gujarat Kidney and Super Speciality Limited is a regional healthcare provider operating a network of mid-sized multispeciality hospitals across central Gujarat. Established in 2019 and later renamed to reflect its expanding clinical scope, the company focuses on delivering integrated secondary and tertiary care. The organisation is promoted by Dr Pragnesh Yashwantsinh Bharpoda, Dr Bhartiben Pragnesh Bharpoda, Dr Yashwantsinh Motisinh Bharpoda, and Anitaben Yashwantsinh Bharpoda, who collectively bring strong medical and managerial expertise. Today, the company runs seven hospitals and four in-house pharmacies across Vadodara, Godhra, Bharuch, Borsad, and Anand. Its network offers a total capacity of 490 beds, supported by 445 approved and 340 operational beds. Services span inpatient and outpatient care, diagnostics, surgical and critical care, and pharmacy operations within hospital premises. Its business model blends owned and acquired facilities, enabling scalable expansion and efficient integration of new units. With a growing regional footprint, strengthened by technology adoption and speciality-driven services, the company is positioned to meet rising healthcare needs in Gujarat’s semi-urban and urban markets. Discuss on Trading Q&A

IPO Objectives

1. Proposed acquisition of “Parekhs Hospital Private Limited” at Ahmedabad

2. Part payment of purchase consideration for the already acquired hospital i.e. “Ashwini Medical Centre”

3. Funding of capital expenditure requirements of our Company towards setting up of a new hospital exclusively for women’s health care in Vadodara;

4. Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital at Vadodara location

5. Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by our Company and

6. Funding inorganic growth through unidentified acquisitions and General Corporate Purposes.

Company Promoters

Anitaben Yashwantsinh Bharpoda

Bhartiben Pragnesh Bharpoda

Pragnesh Yashwantsinh Bharpoda

Yashwantsingh Motisinh Bharpoda

Subscription Details

Investor Category Subscription (times)
Qualified Institutions 1.06
Non-Institutional Buyers 5.73
Retail Investors 19.04
Total 25.83
img

How to Apply for IPO

img img

Login

Login to your Bigul Account

Select Lots & Price

Choose the number of lots and price

UPI ID

Enter your UPI ID

UPI Mandate Request

A UPI Mandate Request Triggered

Approve Mandate

Approve the UPI Mandate Request

IPO Allotment

YES Share will be credited. and the amount will be debited

Close

Let's Open Free Demat Account